The intrinsic expression of NLRP3 in Th17 cells promotes their protumor activity and conversion into Tregs
Th17 cells can perform either regulatory or inflammatory functions depending on the cytokine microenvironment. These plastic cells can transdifferentiate into Tregs during inflammation resolution, in allogenic heart transplantation models, or in cancer through mechanisms that remain poorly understood. Here, we demonstrated that NLRP3 expression in Th17 cells is essential for maintaining their immunosuppressive functions through an inflammasome-independent mechanism. In the absence of NLRP3, Th17 cells produce more inflammatory cytokines (IFNγ, Granzyme B, TNFα) and exhibit reduced immunosuppressive activity toward CD8+ cells. Moreover, the capacity of NLRP3-deficient Th17 cells to transdifferentiate into Treg-like cells is lost. Mechanistically, NLRP3 in Th17 cells interacts with the TGF-β receptor, enabling SMAD3 phosphorylation and thereby facilitating the acquisition of immunosuppressive functions. Consequently, the absence of NLRP3 expression in Th17 cells from tumor-bearing mice enhances CD8 + T-cell effectiveness, ultimately inhibiting tumor growth.
Authors
- Christophe Hibos (ORCID: https://orcid.org/0000-0003-0191-363X)
- Corentin Richard (ORCID: https://orcid.org/0000-0001-9732-0219)
- Élise Jacquin (ORCID: https://orcid.org/0000-0003-0368-4113)
- Bernhard Ryffel (ORCID: https://orcid.org/0000-0003-2897-8230)
- L. Mayea Milian
- Romain Mary (ORCID: https://orcid.org/0000-0001-8876-7895)
- Théo Accogli (ORCID: https://orcid.org/0000-0002-2783-8482)
- Catherine Paul (ORCID: https://orcid.org/0000-0002-7657-5535)
- Mannon Geindreau (ORCID: https://orcid.org/0000-0003-0926-1998)
- François Ghiringhelli (ORCID: https://orcid.org/0000-0002-5465-8305)
- Frédérique Végran (ORCID: https://orcid.org/0000-0002-4377-1441)
- Romain Boidot (ORCID: https://orcid.org/0000-0001-9956-1737)
- Antoine Bernard (ORCID: https://orcid.org/0000-0002-6932-5685)
- Fanny Chalmin (ORCID: https://orcid.org/0000-0002-0855-9453)
- Étienne Humblin (ORCID: https://orcid.org/0000-0002-4559-6106)
- Sandy Chevrier (ORCID: https://orcid.org/0000-0003-0805-791X)
- Lionel Apétoh (ORCID: https://orcid.org/0000-0002-2774-438X)
- Mélanie Bruchard (ORCID: https://orcid.org/0000-0003-0004-2887)
Institutions
- Université d'Orléans (FR)
- Indiana University Health (US)
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- École Pratique des Hautes Études (FR)
- Université de Bourgogne (FR)
- Université Paris Sciences et Lettres (FR)
- Centre Georges François Leclerc (FR)
- Immunologie et Neurogénétique Expérimentales et Moléculaires (FR)
- Indiana Cancer Consortium (US)
- Genomic and Immunotherapy Medical Institute (FR)
- Indiana University – Purdue University Indianapolis (US)
Publication Details
- Journal
- Cellular and Molecular Immunology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1038/s41423-025-01281-y
- Citations
- 21
- Primary Topic
- Inflammasome and immune disorders
- Type
- article
- Field-Weighted Citation Impact
- 16.93
Funders
- Agence Nationale de la Recherche
- Institut National de la Santé et de la Recherche Médicale
- Fondation ARC pour la Recherche sur le Cancer
- Ligue Contre le Cancer
- Fondation de France
- Université de Bourgogne
- Ministère de l'Enseignement Supérieur et de la Recherche
- Institut National Du Cancer